Live Breaking News & Updates on Australian Stock Exchange Msb Ax|Page 1

Stay updated with breaking news from Australian stock exchange msb ax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

United States Food & Drug Administration (FDA) Grants

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory. ....

United States , Steve Dabkowski , Silviu Itescu , Paul Hughes , Drug Administration , Corporate Communications Investors , Australian Securities Exchange , Mesoblast The Company , Drug Designation Program , Mesoblast Limited Nasdaq , Journal Of The American College Cardiology , United States Food , Orphan Drug Designation , Rare Pediatric Disease Designation , Chief Executive Silviu Itescu , Cardiovascular Surgery Open , Priority Review Voucher , Hypoplastic Left Heart Syndrome , Mesoblast Limited , Patients With Heart , American College , Private Securities Litigation Reform Act , Australian Stock Exchange Msb Ax , Mesoblast Limited ,

Appendix 4C Quarterly Activity Report for Quarter Ended

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for. ....

United States , United Kingdom , Steve Dabkowski , Silviu Itescu , Paul Hughes , Marrow Transplant Clinical Trials Network , National Institutes Of Health , Program In Chronic Heart Failure , Australian Securities Exchange , Corporate Communications Investors , Pharmaceuticals Co , Mesoblast Limited Nasdaq , Program In Pediatric Congenital Heart Disease , Chief Executive Silviu Itescu , Rare Pediatric Disease , Host Disease , Adult Phase , National Institutes , Pediatric Congenital Heart Disease , Chronic Heart Failure , Reduced Ejection Fraction , Cardiovascular Surgery Open , Biologics Licensing Application , Priority Review Voucher , Regenerative Medicine Advanced Therapies , Low Back Pain ,

United States Food & Drug Administration (FDA) Grants

FDA GRANTS MESOBLAST RARE PEDIATRIC DISEASE DESIGNATION FOR REVASCOR® (REXLEMESTROCEL-L) IN CHILDREN WITH CONGENITAL HEART DISEASE. ....

United States , Silviu Itescu , Steve Dabkowski , Paul Hughes , Mesoblast Limited Nasdaq , Drug Administration , Journal Of The American College Cardiology , Corporate Communications Investors , Australian Securities Exchange , Revascor Increases Size Of Left Heart Chamber , Mesoblast The Company , Left Heart Chamber , Improves Surgical Outcomes , Hypoplastic Left Heart Syndrome , Results Published , Cardiovascular Surgery , United States Food , Rare Pediatric Disease , Biologics Licensing Application , Priority Review Voucher , Cardiovascular Surgery Open , Chief Executive Silviu Itescu , Mesoblast Limited , Patients With Heart , American College , Private Securities Litigation Reform Act ,

Mesoblast Files for Orphan Drug and Pediatric Rare Disease

NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory. ....

United States , Steve Dabkowski , Paul Hughes , Mesoblast The Company , Mesoblast Limited Nasdaq , Australian Securities Exchange , Journal Of The American College Cardiology , Corporate Communications Investors , Drug Administration , United States Food , Cardiovascular Surgery Open , Mesoblast Limited , Patients With Heart , American College , Private Securities Litigation Reform Act , Australian Stock Exchange Msb Ax , Mesoblast Limited ,

Mesoblast Partners With Blood and Marrow Transplant

NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory. ....

New York , United States , Green Bay , Medical College Of Wisconsin , Paul Hughes , Steve Dabkowski , Silviu Itescu , John Levine , National Institutes Of Health , United States National Institutes Of Health , Core Transplant Centers Consortia , Blood Institute , United States Food Drug Administration , School Of Pharmacy , Australian Securities Exchange , Steering Committee , Corporate Communications Investors , Clinical Research Organization , Drug Administration , Emmes Company , Mesoblast The Company , Marrow Transplant Clinical Trials Network , International Blood , Mesoblast Limited Nasdaq , Icahn School Of Medicine At Mount Sinai , Marrow Transplant Research ,